Sichuan Kelun-Biotech Biopharmaceutical Co Ltd banner
S

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990

Watchlist Manager
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Watchlist
Price: 397.6 HKD -4.79% Market Closed
Market Cap: HK$92.7B

Income Statement

Earnings Waterfall
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Income Statement
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2023 Jun-2024 Dec-2024 Jun-2025
Revenue
Interest Expense
84
8
4
0
Revenue
1 540
N/A
1 877
+22%
1 933
+3%
1 501
-22%
Gross Profit
Cost of Revenue
(781)
(717)
(659)
(644)
Gross Profit
759
N/A
1 160
+53%
1 274
+10%
857
-33%
Operating Income
Operating Expenses
(1 213)
(1 344)
(1 486)
(1 634)
Selling, General & Administrative
(201)
(215)
(346)
(492)
Research & Development
(1 031)
(1 165)
(1 206)
(1 165)
Depreciation & Amortization
0
(32)
0
0
Other Operating Expenses
19
68
66
24
Operating Income
(454)
N/A
(184)
+60%
(212)
-16%
(777)
-266%
Pre-Tax Income
Interest Income Expense
(13)
85
70
49
Non-Reccuring Items
(1)
(1)
(0)
(0)
Pre-Tax Income
(468)
N/A
(100)
+79%
(143)
-43%
(727)
-410%
Net Income
Tax Provision
(106)
(133)
(124)
5
Income from Continuing Operations
(574)
(233)
(267)
(722)
Net Income (Common)
(574)
N/A
(233)
+59%
(267)
-15%
(722)
-171%
EPS (Diluted)
-2.62
N/A
-1.05
+60%
-1.2
-14%
-3.16
-163%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett